Categories: In Case You Missed It

GLP-1 Patient Safety at Risk


As demand for GLP-1 medications skyrockets, patients are increasingly targeted with compounded knockoffs that are not FDA approved and do not meet federal safety or quality standards. Many are mass-produced using unverified foreign ingredients and marketed deceptively as “personalized” care.

The Jet Set

Recent Posts

American Airlines Introduces First-Class Light Bites Menu on Chicago-New York Flights

American Airlines is introducing light bites for first-class passengers on its Chicago-New York flights. The…

10 hours ago

United Airlines Restricts Third-Party AI Agents From Booking Flights

United Airlines announced plans to restrict unauthorized third-party AI agents or assistants from accessing its…

20 hours ago

FAA: US Flight Schedules Expected to Return to Normal by Sunday After Ground Stop

US flight schedules are expected to return to normal by the end of Sunday, two…

1 day ago

United Brings Spotify to Its Seatback Screens

United Airlines partnered with Spotify a little over a year ago. Now, the airline is…

1 week ago

Federal Judge Rejects Delta’s Bid to Dismiss Window Seat Lawsuit

A federal judge in New York denied Delta Air Lines’ request to dismiss a lawsuit…

1 week ago

JetBlue Hikes Checked Baggage Fees Again, Marking Second Increase This Year

JetBlue has raised its baggage fees for the third time in less than a year,…

1 week ago